Psychology by BogdanovaThe Encyclopedia of Psychology for the Artificial Era

RESEARCH DOSSIER

Mental Health, Screening, and Care Systems in Elite Sport

Abstract. Mental health in elite sport is a clinical, psychological, organizational, and public-health problem whose defining feature is the interaction between athlete needs and the institutions that identify, interpret, and respond to them. This integrative research monograph examines how symptoms arise and are measured, how validated screening is translated into clinical assessment, and how confidentiality, safeguarding, organizational power, referral pathways, and continuity of care shape outcomes. Its evidence base prioritizes original instrument-validation studies, athlete interviews and intervention trials, systematic reviews and meta-analyses, the 2019 and 2026 International Olympic Committee (IOC) consensus statements, and the 2026 IOC Sport Mental Health Assessment Tool 2 (SMHAT2). The synthesis distinguishes screening from diagnosis, prevalence from service demand, literacy from actual care access, and individual treatment from changes in the sporting environment. The principal conclusion is that a screening program constitutes a meaningful health service only when competent interpretation, timely assessment, patient-governed confidentiality, crisis response, sustained treatment, and accountable organizational improvement follow detection. Research priorities include longitudinal validation, direct measures of treatment completion and outcomes, intervention effectiveness, equity across sport populations, and independent evaluation of the sport-care interface.

Keywords: elite athletes; athlete mental health; sport psychiatry; mental health screening; SMHAT2; psychological distress; psychometrics; clinical assessment; help-seeking; referral pathways; confidentiality; safeguarding; service organization; implementation science; equity; athlete well-being.

The Research Object and the Sport-Care Ecology

The subject of this Research Dossier is the organization of mental health recognition and care in elite sport. It encompasses the psychological states experienced by athletes, the instruments used to detect potential difficulties, the clinical processes that establish what those difficulties mean, and the institutions responsible for making care accessible. Its unit of analysis is therefore a linked service ecology: athletes and their circumstances; clinicians and their obligations; coaches, teams, federations, and governing bodies; and the practical arrangements that connect an athlete's disclosure to appropriate assistance.

Mental health encompasses emotional, cognitive, behavioral, interpersonal, and functional dimensions. Psychological distress indicates an experience of strain that may be transient, sustained, disabling, or associated with a diagnosable disorder. A mental disorder refers to a clinically evaluated syndrome assessed in accordance with applicable diagnostic criteria and professional judgment. Mental well-being involves capacities and experiences such as connectedness, functioning, purpose, and perceived safety. These constructs can overlap without becoming interchangeable. An athlete may score above a symptom-screening threshold without receiving a psychiatric diagnosis; another may have significant clinical needs while minimizing questionnaire responses because selection or disclosure feels threatening.

Elite sport intensifies the importance of this distinction. Competitive schedules, public scrutiny, contractual insecurity, injury, travel, and hierarchies of authority can shape both the development of symptoms and the willingness to report them. The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) locates athlete mental health within the entire sporting environment and explicitly connects routine assessment to organizational action. Its recommendations are a contemporary consensus synthesis, while the experimental effectiveness of every proposed service component remains a separate empirical question.

A care system can be represented analytically as a pathway involving recognition, accessible contact, assessment, agreed treatment, follow-up, and re-entry after interrupted care. Failure at any step changes the effective value of earlier steps. A confidential questionnaire that identifies symptoms but does not lead to an appointment is a detection exercise. A psychiatrist who is available but perceived as an instrument of team selection may remain inaccessible. Successful care is judged by meaningful access, ethical practice, symptom and functioning outcomes, continuity, and the athlete's ability to exercise informed choice.

Historical Development of Athlete Mental Health Research

Sport psychology historically developed influential programs in motivation, anxiety, performance preparation, psychophysiology, group processes, and coping. The maturation of athlete mental health research required additional attention to psychiatric symptoms, injury-related adjustment, clinical validity, healthcare provision, and institutional vulnerability. General models of competitive anxiety could illuminate particular processes, but they were not designed to function as diagnostic tools. This difference in scientific purpose remains central to contemporary work.

A major integrative point was the Rice, S. M., Purcell, R., De Silva, S., Mawren, D., McGorry (2016), which assessed the available evidence concerning mental health and substance use among elite athletes and described substantial methodological variation. It helped establish the need to study elite athletes as a population with particular exposures and reporting conditions. The Reardon, C. L., Hainline, B., Miller Aron, C., Baron, D., Ba (2019) broadened clinical attention across multiple disorder groups and emphasized environmental conditions alongside individual assessment.

During the same period, research on service access exposed the practical distance between awareness and care. Gulliver, A., Griffiths, K. M., & Christensen, H (2012) conducted focus groups with 15 young elite athletes and identified stigma, limited literacy, prior experiences, interpersonal encouragement, and trust in providers as factors in help-seeking. Purcell, R., Gwyther, K., & Rice, S. M (2019) subsequently articulated an early-intervention framework whose premise was that education alone could not satisfy an athlete's clinical needs.

The creation of the Gouttebarge, V., Bindra, A., Blauwet, C., Campriani, N., Cur (2021) translated this agenda into a proposed recognition-and-referral procedure. Further field experience and measurement critique led to the Gouttebarge, V., Bindra, A., Blauwet, C., Currie, A., Hainli (2026), accompanied by the substantially expanded Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026). The latest revision matters historically because the assessment design shifted toward universal disorder-specific screening followed by conditional screening and professional clinical evaluation. The former APSQ-first triage algorithm should therefore be described as a historically important predecessor rather than silently treated as the current tool.

This chronology shows a change in research questions. Early inquiry asked whether elite athletes experience recognizable mental health problems. Later work asked how common reported symptoms are, how instruments behave in sport populations, why athletes avoid formal help, and which institutional designs might deliver competent care. Current research must finally test whether organizational adoption produces safer and more effective health outcomes.

Populations, Constructs, and Diagnostic Boundaries

The category of elite athlete varies between studies. It may include professional league competitors, national-team athletes, Olympic and Paralympic athletes, high-performance collegiate competitors, and athletes in specialized national development pathways. These groups differ in age, employment status, healthcare access, sport demands, income, and organizational protection. The population eligible for the IOC SMHAT2 includes professional, Olympic, Paralympic, and collegiate athletes aged 16 years and older, as specified in its Gouttebarge, V., Bindra, A., Blauwet, C., Currie, A., Hainli (2026). That operational boundary belongs to the instrument and does not define every elite-sport research population.

Three outcome families need separate measurement. Symptom indicators quantify experiences such as low mood, worry, sleep disturbance, or problematic substance use. Clinical outcomes concern diagnoses, severity, impairment, risk, and treatment response established in professional evaluation. Service outcomes measure whether an athlete recognizes a need, can obtain an appointment, enters care, remains engaged, and finds treatment acceptable and useful. Studies reporting an improvement in mental health literacy have not necessarily demonstrated improved clinical outcomes or greater service utilization.

Research also distinguishes current athletes from retired athletes, competitors from coaches, and participation-level effects from sport-specific exposures. The 2026 systematic evidence review by Gouttebarge, V., Bilgoe, S. C., Gorczynski, P., Hitchcock, M (2026) explicitly includes active and former athletes and entourage members, while reporting symptom prevalence rather than diagnostic prevalence. Aggregating these populations into a single mental-disorder statistic would erase essential design and construct differences.

A further distinction concerns sport-related behavior and disorder criteria. Intense preparation, anticipatory arousal, fatigue after competition, and temporary disappointment may occur in healthy high-performance adaptation. Persistent or severe impairment, acute danger, compulsive symptoms, or marked departures from an athlete's usual functioning warrant appropriate clinical assessment. Context informs the meaning of observed symptoms; it does not authorize either blanket normalization or automatic pathologization.

Epidemiology and the Interpretation of Prevalence

Prevalence estimates answer a question only when their population, measurement instrument, observation period, threshold, and sampling method are specified. A percentage of questionnaire-positive athletes describes the proportion meeting a screening definition in the observed sample. It cannot be reported as the prevalence of clinician-confirmed psychiatric disorders unless diagnostic verification actually occurred.

In their Gouttebarge, V., Bilgoe, S. C., Gorczynski, P., Hitchcock, M (2026), Gouttebarge and colleagues included 72 studies of self-reported mental health symptoms, not clinically diagnosed mental disorders. The analyzed active-athlete samples ranged from 2,596 to 10,927 across particular outcomes, with pooled symptom estimates spanning approximately 4% for drug misuse to 33% for distress. Samples of former athletes ranged from 2,070 to 3,405 in the corresponding meta-analyses, with estimates from about 12% for depression symptoms to 28% for alcohol misuse. The authors explicitly caution that heterogeneity limits the interpretation of pooled estimates. Each figure therefore refers to a different outcome and sample composition; the endpoints of these ranges are not a unified risk score.

The earlier Gouttebarge, V., Castaldelli-Maia, J. M., Gorczynski, P., Ha (2019) was important for synthesizing the emerging evidence, but later studies and changed inclusion criteria prevent its figures from being treated as a fixed contemporary population baseline. Comparisons with nonathletes are especially sensitive to age, sex and gender composition, injury history, sport, retired status, and response conditions. A response rate from a team survey may also reflect who feels safe enough to participate.

Differences among sports are scientifically meaningful but hard to estimate without adequate stratification. Individual and team sports, aesthetic and weight-class disciplines, disability categories, contact sports, publicly scrutinized leagues, and sports with short career spans can differ in exposures and norms. In a clinical population the association between injury and distress may arise through pain, loss of participation, financial instability, changed identity, or previous vulnerability. Observational association does not distinguish these pathways by itself.

The practical implication for health planning is that a pooled percentage should never determine an individual athlete's need or a team's staffing capacity on its own. Service planning requires local surveillance, access metrics, athlete preferences, case complexity, appropriate denominators, and professional estimates of clinical workload.

Psychological Exposures and Causal Pathways

Elite athletes encounter ordinary life stressors as well as contextual exposures related to sport. Relevant candidate pathways include social evaluation, competitive uncertainty, injury, sleep disruption, travel, conflict with coaches, coercive control, financial pressures, insecure selection, isolation, exposure to abuse, and difficulties during career change. Some exposures can influence symptoms through threat appraisal, emotional regulation, disrupted recovery, reduced social support, or changes in perceived control. Other relationships may be bidirectional: a distressed athlete may experience poorer sleep and subsequently report greater stress, while an unsafe environment may jointly influence both.

A biopsychosocial account describes how individual susceptibility, current demands, social relations, and biological states interact. It becomes testable when investigators define exposures before outcomes, measure plausible mediators, account for preexisting difficulties and injury, and compare trajectories across relevant conditions. The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) recommends addressing stressors and protective features within training and competition environments. This recommendation identifies targets for prevention; it is not equivalent to experimental proof that every proposed environmental measure reduces psychiatric disorder incidence.

Protective factors include accessible supportive relationships, trustworthy clinical services, recovery opportunities, autonomy, respectful coaching, and the ability to communicate concerns. Their role depends on context. Social support can be helpful when it preserves privacy and choice, while a coach who is simultaneously a source of threat cannot automatically be assigned responsibility for confidential disclosure. Similarly, resilience is a psychological process with environmental preconditions, not a justification for unmodified harmful demands.

Designs suited to causal inquiry include prospective repeated-measure cohorts, quasi-experiments around changes in sport policies, cluster-randomized trials of service packages where ethically and practically feasible, and qualitative studies explaining mechanisms and unanticipated consequences. Each method illuminates a different level of the service ecology.

Organizational Power and Athlete Autonomy

High-performance organizations combine welfare responsibilities with decisions about selection, employment, playing time, contracts, and reputation. This concentration of authority changes the psychology of disclosure. Athletes may rationally anticipate that information about symptoms will alter how they are judged, even when official messages encourage openness. A formally available service will be experienced as accessible only when its governance is credible.

The Cosh, S. M., McNeil, D. G., Jeffreys, A., Clark, L., & Tully (2024) identified fear of deselection and concerns about confidentiality among sport-specific barriers to help-seeking. These are organizational variables, not merely deficiencies in individual knowledge. An athlete who understands depression may still decline an appointment if information flows back to decision-makers without clear limits.

Autonomy includes meaningful informed consent, the capacity to select a clinician when possible, understanding the limits of confidentiality, and participation in decisions about disclosure and return to sport. An environment that pressures athletes to accept screening as a test of loyalty can distort responses and undermine clinical trust. Health personnel should be able to distinguish their duty to care for the patient from requests for information intended to optimize selection. Where clinical and team roles intersect, professional obligations, legal requirements, and explicitly defined minimum-necessary information sharing govern practice.

Institutional responsibility also includes the conduct of coaches, the availability of independent complaints channels, protection against retaliation, and regular audit of referral outcomes. The degree to which these arrangements improve outcomes must be empirically evaluated. Describing safeguards in a policy is evidence of institutional intent; implementation, athlete comprehension, and observed safety determine whether the safeguards operate.

Screening, Surveillance, and Clinical Diagnosis

Screening identifies people who may require additional assessment through a standardized process. Its outputs are probabilistic indicators associated with a specified threshold. Surveillance follows health patterns over time for clinical response or population-level learning. Diagnosis is a professional determination based on detailed history, clinical evaluation, relevant diagnostic criteria, functional impairment, differential considerations, and appropriate risk assessment.

A screening strategy should be understood as a complete detection-and-response system. Its accuracy depends on the scale, threshold, population prevalence, administration conditions, and reference standard; its clinical value additionally depends on what follows the result. False-positive responses can lead to unnecessary anxiety and resource use. False-negative results can produce misplaced reassurance, particularly when athletes underreport or symptom patterns are outside a questionnaire's scope. A negative screen never closes the possibility of a relevant clinical concern when history, observed change, or acute risk indicate the need for assessment.

The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) distinguishes episodic screening from longitudinal athlete-report surveillance, clinician-recorded surveillance, and event-related surveillance. This distinction prevents a single annual questionnaire from being mislabeled as continuous monitoring. It also distinguishes the needs of a clinical team receiving confidential reports from those of researchers analyzing de-identified population trends.

The governance question is inseparable from measurement. Athletes should know who can view individual answers, whether records are clinical or administrative, when follow-up will happen, and what happens if safety concerns arise. Data collected without a functioning clinical response system carry risks that cannot be resolved by adding another questionnaire.

The IOC Assessment Tools From SMHAT-1 to SMHAT2

The initial Gouttebarge, V., Bindra, A., Blauwet, C., Campriani, N., Cur (2021), published online in 2020 and appearing in a 2021 journal issue, used the Athlete Psychological Strain Questionnaire (APSQ) for initial triage, followed when indicated by disorder-specific screens and a subsequent intervention or clinical assessment stage. The APSQ is a ten-item sport-context measure of psychological strain. Its presence in the original tool reflected the effort to detect symptoms through an athlete-relevant entry point.

The Gouttebarge, V., Bindra, A., Blauwet, C., Currie, A., Hainli (2026) revises this architecture. The updated procedure uses universal screening with five disorder-specific questionnaires and two additional substance-use questions; conditional screening with two disorder-specific questionnaires when indicated; and a third stage supporting professional clinical assessment and treatment decisions. The universal stage addresses anxiety, depressive symptoms, sleep disturbance, disordered eating, alcohol misuse, and reported cannabis and tobacco/nicotine use. Conditional assessment incorporates post-traumatic stress symptoms and broader substance-misuse questions when triggered. The exact instrument package and thresholds belong to the official tool, which should be implemented unmodified and interpreted by appropriately qualified personnel.

The 2026 development paper describes a multi-stage process drawing on literature review, prior-user experience, misclassification analysis, content validity, feasibility, and revision. This is substantive developmental evidence, but feasibility and content validity are distinct from a definitive prospective demonstration that the tool reduces disorder burden or improves treatment completion. The authors explicitly call for further validation across sports and cultures.

The updated approach is intended for professional, Olympic, Paralympic, or collegiate athletes at least 16 years old. Licensed healthcare professionals may administer the screening components, while clinical assessment and treatment must remain under appropriately qualified medical or mental health professionals. Routine use is proposed in the preseason and may recur at other points in a competitive year or after significant events, including injury, major competition, and career change. A confidential, structured feedback process matters even for athletes who do not cross a screening threshold.

The scientific distinction between SMHAT-1 and SMHAT2 has a practical consequence for editorial currency. The first tool explains the development of elite-sport screening and the APSQ-first historical model. The updated tool is the contemporary IOC assessment design as of November 2026. Local validation, clinical judgment, and organizational safeguards remain necessary regardless of instrument generation.

Measurement Validity, Thresholds, and Misclassification

Psychometric validity requires evidence that the intended interpretation of a score is supported by its underlying construct, response behavior, and comparison with an appropriate reference. Reliability concerns the consistency of measurement under defined conditions. Internal consistency alone cannot demonstrate that a questionnaire identifies a clinical disorder, and agreement between two questionnaires does not replace assessment against a valid clinical reference.

Instrument choice is consequently an issue of fit to purpose. General instruments such as the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) derive from studies in healthcare populations. Their foundational validation studies by Kroenke, K., Spitzer, R. L., & Williams, J. B. W (2001) and Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B (2006) established useful clinical screening properties in the populations investigated. They do not establish measurement invariance among every sport, age group, language, or disability group. Sport-specific measures may improve contextual relevance while creating different questions about criterion validity, overlap with training fatigue, and transfer across cultures.

The Rice, S. M., Olive, L. S., Gouttebarge, V., Parker, A. G., C (2020) examined sensitivity to alternative cutoffs in a sample of 1,093 elite athletes, with substantially fewer female than male participants. Such sample imbalance is relevant when extending performance claims to women or other underrepresented groups. In the absence of a universal clinical interview reference standard, discrimination against another symptom measure remains evidence of convergent classification, not a verified psychiatric diagnosis.

Two diagnostic parameters illustrate why positive scores must be interpreted in context. Sensitivity is the proportion of affected individuals identified by a specified screening rule; specificity is the proportion of unaffected individuals correctly classified as negative. Positive predictive value additionally depends on the prevalence of the target condition in the tested population. If a threshold is used in a lower-prevalence group, the proportion of positives that correspond to actual clinical cases may decline even if sensitivity and specificity remain unchanged. Institutions therefore need a plan for evaluating positives, explaining uncertainty, and ensuring that low scores do not override serious clinical indicators.

Longitudinal measurement adds difficulties. Apparent change may represent genuine improvement, seasonal variation, response shift, changes in disclosure safety, or random error. Repeated questionnaires require an interpretation strategy that considers measurement error and clinically meaningful change. A team's aggregate decline in reported symptoms could signal improved well-being or increased reluctance to disclose after an adverse confidentiality incident. Independent qualitative feedback and service-performance measures help adjudicate these possibilities.

The Gouttebarge, V., Bindra, A., Blauwet, C., Currie, A., Hainli (2026) addresses content validity and feasibility, while recognizing the continuing need for prospective, culturally diverse validation. Evaluation should include sensitivity, specificity, predictive values, differential item functioning, missingness, nonresponse, acceptability, and clinical outcomes attributable to the pathway. These are distinct claims and should not be collapsed into a single phrase such as validated screening.

Clinical Domains and Differential Assessment

A comprehensive athlete mental health assessment investigates symptom pattern, duration, associated impairment, medical conditions, substances, environmental stressors, prior history, safety concerns, and personal goals. Depression, anxiety, sleep problems, trauma-related symptoms, disordered eating, and substance use represent important domains identified in the Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026). Disorders involving attention, mood elevation, psychosis, compulsive behavior, gambling, and other clinically significant presentations may also require assessment when indicated by history and presentation. The selection of an assessment pathway should follow actual clinical concerns rather than the limited content of any screening battery.

A depressed-mood score alone cannot determine whether a person meets diagnostic criteria for a depressive disorder. Clinicians must assess course and functional consequences, differential psychiatric and medical explanations, medication effects, relevant life events, and safety. Similarly, anxiety before an important event may be an expected response to uncertainty, while persistent worry or panic with significant impairment merits closer examination. Sleep disturbance can relate to travel, circadian misalignment, pain, workload, anxiety, or other medical disorders. An assessment that treats all sleep problems as a single psychiatric mechanism could produce inappropriate recommendations.

Eating disturbances require particular caution in sporting environments where body weight, energy availability, and performance are tightly connected. Assessment may involve eating-disorder psychopathology, nutrition, endocrine and other medical consequences, and sport-specific pressures. Relative energy deficiency in sport is a broader physiological syndrome and is not synonymous with a mental disorder. The separate Research Dossier on eating disorders, body image, and relative energy deficiency is the designated site for detailed mechanisms; this monograph examines screening and coordination of appropriate care.

Risk evaluation is a clinical responsibility rather than the automatic output of a score. Thoughts of suicide or self-harm, psychosis, dangerous substance-related states, acute medical complications of restrictive intake, or signs of coercion or abuse require professional assessment proportionate to the presentation. Clinical judgment and local emergency protocols determine the response. A research article cannot replace individual diagnosis, emergency triage, or a treating clinician's decisions.

Mental and Physical Health as Interacting Processes

Physical and mental health frequently influence one another. Pain, concussion, serious injury, chronic illness, endocrine disruption, sleep disturbance, and fatigue can contribute to distress, while depression or anxiety may affect recovery behavior, perceived exertion, self-care, and treatment engagement. The existence of these relationships does not establish that a particular athlete's symptoms are caused by sport or by an underlying psychiatric condition.

Interdisciplinary assessment is therefore essential. Sports medicine clinicians may evaluate injury and medical contributors; mental health professionals evaluate psychiatric and psychological dimensions; qualified nutrition and allied health professionals contribute within their scopes. Coordination should use patient consent and clinically necessary disclosure rather than unrestricted exchange of sensitive notes across the sporting organization. An athlete's physical rehabilitation and psychiatric care may share goals while retaining separate professional responsibilities.

The Patricios, J. S., Schneider, K. J., Dvorak, J., Ahmed, O. H (2023), illustrates the importance of differentiated clinical assessment when symptoms such as headache, sleep disruption, mood disturbance, and cognitive difficulty occur after head injury. It does not justify inferring concussion or a mental disorder from these symptoms alone. The overlap increases the need to document timing, clinical examination, and alternative explanations.

Evidence concerning mental health and performance is often bidirectional and confounded. A distressed athlete may train differently, and persistent selection or performance difficulties may themselves increase distress. When testing interventions, investigators should report mental health and performance as separate outcomes. A faster return to competition does not necessarily indicate psychological recovery, and improvement on a symptom scale does not automatically show restored function in a demanding sporting environment.

Injury, Competition Cycles, and Career Transitions

Competition and training provide temporal structure to athletes' lives. Major championships, roster decisions, prolonged travel, interrupted training, serious injury, and retirement can alter daily routines and support networks. The relationship between these transitions and mental health depends on the athlete's prior history, resources, identity commitments, sense of agency, and institutional response.

The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) recommends mental health assessment and support at significant transitions and after critical events, including injuries. An event-triggered review may detect concerns missed at preseason screening. Yet screening every athlete after an event has practical implications for capacity and privacy. Evidence-based local pathways should specify when contact is offered, who interprets responses, and which follow-up resources are available.

Injury-related distress can concern uncertainty, pain, isolation, loss of valued activity, altered bodily confidence, fear of reinjury, or concern about losing a contract. Some injuries create medical risk that requires specialized assessment; the associated psychological response varies substantially. A clinician should not treat distress as an inevitable consequence of injury or dismiss symptoms as an ordinary price of competition.

Retirement and deselection present different care challenges. The athlete may lose regular contact with team clinicians at the same moment that role transition, financial pressures, or identity disruption intensify. Continuity agreements, insurance arrangements, and access to external services become relevant service variables. The causal effects of particular transition programs require better longitudinal and comparative study. This dossier includes continuity of care; the detailed psychology of identity reconstruction belongs to the neighboring athletic-career transition dossier.

Safeguarding, Trauma, and Organizational Prevention

The sporting environment may expose athletes to emotional, physical, or sexual abuse, discrimination, humiliation, coercive authority, and retaliation. These experiences can affect mental health directly and can change whether athletes trust the care system. Trauma-informed practice recognizes the possible effects of threat, respects autonomy, and avoids unnecessary re-exposure during assessment. It remains crucial to distinguish the presence of a traumatic experience from a diagnosis of post-traumatic stress disorder.

The Tuakli-Wosornu, Y. A., Burrows, K., Fasting, K., Hartill, M (2024) provides a dedicated organizational framework for recognizing and preventing abuse and responding to disclosures. Safeguarding concerns institutional authority, reporting channels, investigation arrangements, and protection of athletes. Clinical care, legal reporting, and organizational investigation can intersect, but they have distinct purposes and standards. A clinician supporting an athlete should not be informally converted into the organization's investigator.

Effective protection requires credible reporting options outside the athlete's immediate chain of command, clear anti-retaliation measures, known statutory and contractual reporting obligations, and independent oversight of outcomes. These features should be investigated as measurable institutional practices. Merely publishing an anti-abuse statement does not establish that a harmed athlete receives an impartial response or uninterrupted access to treatment.

Clinical confidentiality requires special handling when abuse involves minors or another safeguarding duty. The athlete should be informed in advance about legally required disclosures and how information will be limited to the appropriate recipients. Procedures must be adapted to relevant jurisdiction and age. Organizations operating internationally cannot assume that one national rule governs every competition or team encounter.

Stigma, Literacy, and Help-Seeking

Stigma can involve anticipated judgment, internalized negative beliefs, fear of being perceived as weak, and expectations that disclosure will damage an athletic career. Mental health literacy includes knowledge of symptoms, treatment options, and ways to access appropriate services. These mechanisms are related but distinct. Greater knowledge can improve recognition without eliminating organizational consequences or distrust.

The early Gulliver, A., Griffiths, K. M., & Christensen, H (2012) used focus groups with fifteen young elite athletes to explore barriers and facilitators. Such a design provides rich evidence about participants' perceptions, not a population prevalence estimate. Its themes—stigma, awareness, trusted relationships, and provider preferences—became important hypotheses for later service research.

A subsequent Gulliver, A., Griffiths, K. M., Christensen, H., Mackinnon (2012) tested online mental health help-seeking interventions among elite athletes. Although some literacy-related outcomes improved, the study did not establish a reliable increase in formal help-seeking behavior. The distinction between changing attitudes and obtaining care is fundamental. Trials with inadequate statistical power, small follow-up samples, or short observation windows should be interpreted within those design constraints.

The Cosh, S. M., McNeil, D. G., Jeffreys, A., Clark, L., & Tully (2024) included twenty-two studies and pooled formal help-seeking from eleven studies comprising 3,415 athletes. The estimated proportion was 22.4% (95% confidence interval, 16.2%–30.2%), with very high heterogeneity (I² = 95.7%). The authors identified confidentiality concerns, fear of deselection, team culture, athlete identity, stigma, and literacy among barriers. This figure describes the particular studies and operational definitions included; it does not measure the percentage of all athletes who ever need treatment, nor does it imply that every person who did not seek care had unmet clinical need.

Services should therefore be evaluated by observed contact, assessment, uptake after indicated screening, appointment delay, treatment engagement, and outcomes. Peer advocates and trusted role models may support recognition and normalize help-seeking, but they cannot substitute for independent clinical care. Education programs are most credible when they specify exactly how a person can obtain confidential assistance.

Clinical Independence and Institutional Conflict

An athlete's treating professional owes clinical duties to the patient. Sporting organizations legitimately have safety and performance responsibilities, but these roles can create conflicts when the same person is expected to advise both on medical care and selection or employment decisions. The conflict may be structural even when every professional is personally conscientious.

Credible organizational designs specify who controls the clinical record, which professionals make diagnosis and treatment decisions, who determines participation-related medical clearance where relevant, and how independent consultation can be obtained. Teams should clearly distinguish medical evaluation from administrative decision-making. A contract requiring a blanket release of therapy notes for coaching purposes would raise different ethical and possibly legal concerns from a narrowly tailored functional communication authorized by a patient.

The perception of independence is itself a service variable. Even technically adequate privacy safeguards may fail to encourage disclosure if athletes have observed previous misuse or retaliation. Qualitative interviews, confidential experience surveys, and independently monitored complaints can reveal this gap. Evidence from Cosh, S. M., McNeil, D. G., Jeffreys, A., Clark, L., & Tully (2024) supports the empirical relevance of confidentiality and selection concerns, while comparative intervention studies are needed to determine which governance configurations most effectively increase appropriate care access.

Clinical independence must extend to emergency pathways and care after a player's roster changes. A team may cease to be an employer or sponsor, but a patient should have a clear route for obtaining records, continuing clinically indicated care, and understanding available services. Continuity and data portability are meaningful components of an ethical care system.

Multidisciplinary Referral and Care Pathways

A mental health care pathway is an accountable sequence of contact, interpretation, assessment, decision, intervention, and follow-up. It should specify the qualified role responsible at each stage, acceptable response times, escalation criteria, documentation, and the athlete's preferred communication channel. Practical access can require coordination among sports medicine, psychology, psychiatry, nursing, primary care, nutrition, and social support services.

Screening results should be conveyed to an appropriate clinician capable of explaining what the instrument does and does not show. A positive result may lead to a fuller structured interview, medical evaluation, shared discussion of care options, and, where indicated, referral to specialized services. A negative result can still be accompanied by a confidential offer of support or additional assessment when clinical concern exists. Good pathways make it possible to enter care without first completing a formal screening exercise.

Referral is measurable. Investigators can follow the number offered screening, the number completing it, the number requiring follow-up, the number contacted, the number accepting assessment, time to first clinical encounter, treatment initiation, and subsequent attendance. Denominators matter: a referral-acceptance rate calculated only among people who could be contacted hides failures of initial access.

The Purcell, R., Gwyther, K., & Rice, S. M (2019) emphasized accessible, coordinated care adapted to athlete needs. Its status is conceptual rather than proof from a randomized systems trial. The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) likewise provides an evidence-informed framework for assessment, crisis planning, treatment, and organizational support. These recommendations create testable expectations: a functioning pathway should reduce missed referrals, unnecessary delay, fragmentation, and preventable discontinuation of care. Whether a particular implementation meets those expectations requires outcome data.

Acute Risk, Crisis Response, and Escalation

Mental health crises create time-sensitive responsibilities that differ from routine screening and scheduled follow-up. A crisis response may be required when a clinician identifies acute risk of suicide or serious self-harm, severe disorganization, dangerous intoxication, severe behavioral disturbance, or another urgent medical or psychiatric condition. Emergencies should be assessed and managed by qualified professionals according to the circumstances and local protocols. Screening questionnaires do not independently make emergency determinations.

The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) calls on elite-sport organizations to establish, rehearse, and regularly revise mental health emergency action plans. These plans should establish responsible personnel, emergency contact routes, arrangements for out-of-hours care, access while traveling, and transfer of relevant information to treating professionals. Competent planning also means knowing which responsibilities remain with a competition venue, a club, a national federation, or an external health service. Without rehearsed jurisdictional and practical arrangements, a written plan may offer limited protection.

There is a critical difference between universal education about warning signs and the professional assessment of an individual in possible danger. Athletes, coaches, and peers can be taught how to seek immediate assistance and how to recognize concerns that warrant urgent clinical review. Their role does not include deciding that a teammate is safe solely from outward behavior, nor imposing informal psychiatric treatment. Communication should support timely connection to the relevant licensed emergency or health service.

After an acute event, follow-up may involve clinical reassessment, continuity arrangements, the athlete's preferences, safeguarding needs, and a carefully determined approach to return to participation. A team's post-event review should consider operational failures while preserving personal health confidentiality. De-identified organizational learning must not be used as a substitute for responsibility to the person affected.

The research challenge concerns effectiveness. Studies should examine response-time reliability, clinician availability, appropriate escalation, continuity after transfer, athlete experiences, and adverse consequences of institutional responses. Because true acute crises may be uncommon in individual sporting organizations, multi-institutional monitoring and carefully designed qualitative audits may be necessary to identify patterns without compromising privacy.

Treatment, Shared Decisions, and Evidence Boundaries

Treatment begins from an appropriate clinical formulation, not from a positive screening score alone. Depending on presentation, severity, patient preferences, access, and relevant professional guidance, an athlete may be offered psychotherapy, medication management, psychological support, treatment of medical contributors, sleep-related care, or coordinated combinations of interventions. The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) recommends individualized, evidence-informed, culturally responsive care that considers the demands of sport.

The general clinical evidence supporting psychological and pharmacological interventions comes principally from research populations broader than elite athletes. Translating this evidence to high-performance sport requires attention to participation schedules, travel, injury, sleep, sport eligibility requirements, potential adverse effects, medical comorbidity, and the athlete's values. No single treatment pathway can be derived from athletic status alone. For particular diagnoses, clinicians should follow current applicable clinical guidelines, monitor outcomes, and exercise individualized judgment.

Psychotherapy may be offered in person or remotely when clinically appropriate, but its effectiveness depends on the condition, intervention, therapist competence, adherence, and study quality. A program that improves knowledge or short-term well-being should not automatically be reported as a treatment for a psychiatric disorder. Distinctions between prevention, low-intensity support, evidence-based clinical treatment, and experimental interventions are essential.

Where medication is clinically indicated, the responsible licensed prescriber assesses the relevant drug's approved indications, safety profile, interactions, potential sports-regulatory considerations, individual medical history, and follow-up. A research monograph need not contain drug-specific prescribing instructions to establish the role of pharmacotherapy in care systems. The correct organizational requirement is access to qualified clinicians and a process for managing the interface between treatment and sport participation.

Shared decision-making requires explanation of reasonable options and uncertainty, documentation of informed preferences, and respect for the patient within applicable legal and safety constraints. Athlete agency includes the right to discuss time away from competition, preferences among treatment settings, and clinically appropriate involvement of trusted people. The quality of this deliberation cannot be inferred simply from whether the athlete attended an appointment.

Continuity, Follow-Up, and Return to Sport

A system can perform well at initial screening and still lose patients through scheduling gaps, travel, team transfers, confidentiality problems, cost, or insufficient specialist availability. Continuity refers to the sustained coordination of clinically indicated care across time, institutions, and changes in an athlete's sport status. It can be assessed through follow-up attendance, successful transfer between providers, continuity of treatment, symptom and functioning trajectories, and patient-reported experience.

Follow-up should be related to clinical need. Symptom improvement, function, adverse effects, safety, and treatment acceptability can all be relevant. A single athlete-reported measure provides useful repeated information but cannot stand in for a comprehensive review when a complex presentation persists. A clinician may need to revisit medical contributors, personal stressors, treatment fit, or new environmental exposures. Access to another professional opinion can be especially important when the treating clinician is also employed by the team.

Return to sport raises intertwined questions of individual well-being, safety, capacity, and rights. The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) emphasizes safety, stability, and function in return-to-sport decisions involving mental health symptoms or disorders. Timelines and decisions require appropriate clinical assessment; a predetermined number of days or a universal questionnaire score would fail to reflect differences among diagnoses, severity, and sporting contexts.

Athletes may fear that continued treatment or medication will be interpreted as inability to compete, while organizations may value rapid return. Governance should keep clinical decisions appropriately independent and preserve the athlete's ability to engage in an informed discussion. Evidence of successful return should incorporate patient-centered clinical outcomes in addition to participation and performance data.

Transitions between clubs, national teams, collegiate settings, disability classifications, and professional or retired status may also interrupt access to care. Research should establish who assumes responsibility for ongoing clinical needs, how records are transferred when authorized, and what support survives a change in organizational affiliation.

Implementation, Workforce, and Service Capacity

An evidence-informed recommendation becomes a functioning service only through implementation. In elite sport, the implementing units may be teams, federations, leagues, competition organizers, education institutions, or independent health providers. These institutions differ in staffing, budgets, clinical infrastructure, national laws, and proximity to specialist services. A routine screening schedule without sufficient follow-up appointments may increase unmet demand and undermine trust.

Implementation science distinguishes the effectiveness of an intervention from its adoption, acceptability, fidelity, feasibility, cost, reach, and maintenance. These dimensions should be measured separately. A service may deliver the planned number of questionnaires while reaching few athletes who face the greatest barriers. Another program may reach many participants but fail to maintain follow-up when staff rotate.

A credible workforce model describes the training and scope of staff who administer screenings, the qualified clinicians responsible for interpretation, referral arrangements, availability outside normal working hours, and safeguards for clinician independence. Nonclinical personnel can contribute to education and appropriate referral but should not make diagnoses or independently manage clinical risk. The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) specifically calls for role-appropriate education across coaches, support staff, and health professionals.

Workforce planning requires local estimates of demand rather than multiplying a pooled prevalence figure by roster size. Some athletes will have positive screens without disorders; others may enter care without screening; case complexity and duration vary. Staffing decisions should therefore draw on actual numbers requesting assessment, service capacity, waiting times, repeat visits, and unmet needs.

Scale creates additional constraints. A national federation may have central specialists but operate across geographically dispersed training environments. Small professional teams may share independent providers. Para sport organizations may require accessible communication or travel arrangements. A service model should be judged on whether the intended athletes can actually use it, with attention to equitable coverage across regions and sports.

Equity, Accessibility, and Cultural Validity

Elite sport is heterogeneous in age, sex and gender, race and ethnicity, disability, sport type, language, nationality, financial resources, professional status, and access to health systems. These differences affect exposure to stressors, the interpretation of symptoms, the feasibility of screening, and the availability of confidential treatment. Treating one predominantly male professional sample as representative of all athletes can generate invalid prevalence estimates and inadequate clinical planning.

The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) addresses the needs of elite Para athletes, adolescent athletes, and athletes in differing cultural and organizational contexts. Disability-related barriers may involve inaccessible facilities, communication formats, classification-related stressors, or limited access to practitioners familiar with particular impairments. An instrument developed with nondisabled participants may require appropriate adaptation and validation before its scores can be interpreted in a new population.

For athletes who are minors, developmental stage, parental or guardian involvement when legally required, educational demands, and safeguarding obligations complicate the consent and confidentiality process. Older athletes navigating retirement, pain, or healthcare transitions have different needs. Ethically sound care should account for the individual's circumstances rather than attaching a single generic pathway to all age groups.

Cultural validity requires more than literal translation of questionnaire items. Researchers should examine whether constructs, thresholds, response categories, and stigma-related meanings function comparably across languages and social settings. Studies may test measurement invariance and differential item functioning, supplement quantitative findings with interviews, and involve relevant athlete communities in instrument design.

Equity audits need transparent denominators: proportion reached, completion, positive-screen follow-up, appointment access, treatment continuation, reported safety, and clinical outcomes within appropriately protected subgroups. Small cell sizes create privacy risks, requiring careful suppression or aggregation. When subgroup differences are identified, analysis should consider institutional access and exposure rather than attributing all variation to individual reluctance or cultural attitudes.

Prevention and Mental Health Promotion

A mental health service should address conditions that influence future risk as well as existing clinical needs. Preventive measures may target abusive coaching practices, bullying, discrimination, excessive or poorly managed demands, social isolation, absence of recovery opportunities, and institutional uncertainty. Promotion of well-being includes building supportive relationships, reasonable access to resources, and trusted participation in decisions affecting one's health.

Universal programs offered to all athletes, targeted prevention for those exposed to identifiable stressors, and indicated interventions for people with emerging symptoms have different target populations and outcomes. Combining them into a single wellness label hides important methodological distinctions. A program aimed at mental health literacy should primarily measure knowledge and relevant behavior; a program aimed at reducing depressive symptoms should use appropriate clinical endpoints and follow-up intervals.

Organizational prevention also requires safeguarding and governance. The Tuakli-Wosornu, Y. A., Burrows, K., Fasting, K., Hartill, M (2024) and Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) support addressing athlete environments and institutional practices. Their recommendations establish priority areas, while randomized and strong quasi-experimental evaluations of complex sport-level prevention packages remain comparatively limited.

The distinction between prevention and performance training is particularly important. Psychological skills interventions can benefit attention, motivation, and stress management, yet their effects on formal psychiatric disorder incidence cannot be inferred from improved performance or short-term self-reported confidence. The relevant scientific question is what outcome was measured, with what comparator, in which athletes, and over what time period.

Measuring Outcomes and Evaluating Care Systems

A service evaluation should distinguish implementation from health impact. Process measures include screening coverage, missing data, contact after positive screening, referral uptake, time to assessment, clinical handoff, follow-up attendance, and crisis-plan rehearsal. Experience measures include perceived privacy, autonomy, cultural responsiveness, accessibility, trust, and acceptability of care. Clinical measures include symptom severity, functioning, diagnosed conditions when assessed, quality of life, and clinically important adverse outcomes.

Measurement should account for possible harms from the service itself. Athletes may experience distress after misunderstood results, unwanted disclosure, inappropriate exclusion, increased surveillance, or a sense that questionnaires are mandatory loyalty tests. These effects belong in the evaluation alongside potential benefits. Confidential adverse-event reporting and independent athlete feedback are necessary to prevent favorable institutional metrics from obscuring negative experiences.

For causal evaluation, a pre-post improvement in the number of referrals establishes a temporal change but not necessarily an effect attributable to the intervention. Secular trends, staff replacement, increased funding, policy changes, and athlete composition may explain the difference. Where practical, controlled interrupted time-series designs, cluster-randomized implementation trials, or appropriately constructed comparison groups can provide stronger evidence. Mixed-methods designs can identify why an ostensibly well-designed program works in one organization and fails in another.

Denominators should be explicit. A screening-completion percentage is based on an eligible population; a referral-conversion percentage may be based on positive screens or clinician recommendations; a treatment-completion percentage depends on the clinical plan. These quantities answer different questions. Comparisons across teams need common definitions and adjustments for differences in case mix and service availability.

Patient-centered outcomes have special status. Faster return to play is a legitimate sporting outcome but should not displace symptoms, safety, functioning, autonomy, or perceived quality of care as indicators of clinical success. The primary beneficiaries of the health system are the people receiving care, and research design should reflect that premise.

Digital Infrastructure and Artificial Systems

Digital questionnaires, secure clinical messaging, telehealth services, wearable data, and algorithmic decision-support tools can change how an elite-sport organization monitors health and organizes appointments. Their scientific assessment requires separate attention to measurement validity, accessibility, confidentiality, clinical safety, operational reliability, and human control over decisions.

A digital screening platform can lower administrative effort, support repeated measures, and automate reminders. It can also amplify problems through unclear access permissions, automated scoring errors, re-identification, cross-border transfer of sensitive data, or routing an urgent disclosure into an unattended inbox. A user interface that promises privacy cannot establish trust independently of the system's actual governance.

Artificial systems can assist with organizing educational material, translating nonclinical content, or identifying missing administrative follow-up. Any use in high-consequence interpretation introduces additional questions about validity, error rates, population shift, explainability, accountability, and clinician oversight. A score prediction is an algorithmic output, not a diagnosis or a substitute for a therapeutic relationship. Athletes need clear disclosure when artificial systems process sensitive information and should know how to reach qualified human professionals.

The Artificial Era provides a broader historical context for distributed cognition and human–artificial institutional organization. In this specific Research Dossier, the empirically testable issue is the effect of technological integration on athlete safety, recognition, clinical access, service continuity, and informed agency. The philosophical identity of Artificial Sapiens is a separate authorial framework; it does not establish the clinical efficacy of AI-supported mental health services.

Research should compare carefully specified digital workflows with appropriate alternatives, predefine outcomes, and include security incidents, missed referrals, subgroup performance, and patient satisfaction. Evaluating a pilot solely by user engagement or number of completed questionnaires would ignore the central purpose of clinical care.

Critical Appraisal of the Evidence Base

The present evidence is strongest in documenting relevant mental health concerns, describing recurring barriers to help-seeking, and identifying the shortcomings of simplistic symptom screening. The Gouttebarge, V., Bilgoe, S. C., Gorczynski, P., Hitchcock, M (2026) contributes extensive observational synthesis while documenting marked heterogeneity and concentrating on self-reported symptoms. Its aggregate estimates cannot establish diagnoses, uniform population baselines, or causal sport-specific effects.

The Cosh, S. M., McNeil, D. G., Jeffreys, A., Clark, L., & Tully (2024) combines quantitative pooling with synthesis of organizational barriers, but the extremely high heterogeneity of the pooled formal help-seeking measure constrains direct transfer of its percentage to any particular league or country. Qualitative research such as Gulliver, A., Griffiths, K. M., & Christensen, H (2012) explains lived reasons for reluctance but cannot measure how frequently each explanation occurs across all sporting populations.

The Gouttebarge, V., Bindra, A., Blauwet, C., Currie, A., Hainli (2026) provides a rationale for a structured modern assessment pathway, with content validity and feasibility evidence. It does not close the need for criterion validation, subgroup calibration, and direct testing of long-term patient outcomes. Historical SMHAT-1 data and APSQ performance findings contribute to the evolution of the instrument without making the newer version's diagnostic or clinical effectiveness self-evident.

The Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller (2026) is an authoritative multidisciplinary synthesis and recommendation process, not itself a randomized trial of the entire care system. Its standards are useful for clinical and institutional planning; empirical tests must still determine comparative effects of specific implementation packages.

Evidence gaps include treatment-response trials focused on diverse athlete populations, long-term post-screening outcomes, continuity after retirement, measured harms of organizational surveillance, culturally valid assessment thresholds, and robust multi-site evaluations of privacy and independence arrangements. Selection bias is likely when only athletes confident in a program's confidentiality participate. Publication bias can favor successful program reports, while variable outcome definitions make synthesis difficult. These limitations justify precise conclusions, transparent methods, and targeted future investigation.

This monograph is a critical integrative scholarly synthesis. It was not conducted as a newly preregistered systematic review and does not report original patient-level datasets or a new meta-analysis. The cited systematic reviews retain the status of the primary research syntheses on their specific questions.

A Research Agenda for Elite-Sport Mental Health Services

The most consequential next step is to evaluate the entire care pathway as an intervention. Research questions should be framed in terms of outcomes that can be observed and attributed to defined mechanisms. Does offering validated screening with guaranteed confidential professional follow-up increase timely assessment compared with the existing pathway? Does an independent clinical governance model improve disclosure safety and appropriate referral uptake? Do transition-specific follow-up arrangements reduce interrupted treatment after deselection, retirement, or transfer? Which adaptations improve accessibility without degrading measurement validity?

Studies should preregister clinically relevant endpoints, identify a clear comparison, measure baseline case mix, and follow participants for enough time to observe service engagement and patient outcomes. Cluster-randomized or stepped-wedge designs may be appropriate when interventions operate at organization level and rollout is ethically justified. Natural experiments can analyze changes in federation policies, provided investigators check for concurrent institutional reforms. Qualitative methods can capture trust, coercion, and disclosure dynamics that numerical process measures miss.

Measurement research should estimate the accuracy and utility of screening instruments with suitable clinical reference standards, including negative-screen follow-up where ethically feasible. It should evaluate age, sport, gender, disability, language, culture, and national healthcare setting. Instrument-related research must report the actual version and administration workflow, particularly now that SMHAT2 supersedes the original APSQ-first algorithm.

Economic and operational evaluation should examine workforce capacity, cost to athletes, time to service, care delivered during travel, and continuity across organizational boundaries. Outcome studies must protect confidential health information and avoid making treatment access contingent on joining research. Athletes should participate in shaping outcomes and evaluating the acceptability of service configurations.

An overarching scientific principle follows: the success of elite-sport mental health care is determined by what the system accomplishes for athletes, including those at risk of exclusion, rather than by the number of forms completed. Progress requires validated recognition, independent clinical judgment, accessible treatment, safeguarding, and transparent evaluation of outcomes.

Conclusion

Mental health in elite sport is inseparable from the systems through which athletes recognize concerns, disclose symptoms, receive clinical assessment, and obtain sustained care. The contemporary research literature establishes that mental health symptoms occur in elite sport, that symptom prevalence varies substantially across measures and populations, and that institutional power, stigma, and confidentiality concerns shape formal help-seeking. The 2026 IOC consensus and SMHAT2 organize these findings into a more comprehensive assessment and care framework.

A functioning service combines valid screening with qualified interpretation, appropriate differential assessment, professional independence, confidentiality, reliable referral, treatment access, emergency arrangements, and continuity during injury and career transitions. Organizational prevention and safeguarding are also relevant to the conditions in which athletes live and compete. Each component can be measured, and their combined effects require rigorous evaluation.

The present evidence supports treating the sport-care ecology as a distinct scientific research object. Its central unresolved problem is not whether elite athletes deserve attention to mental health, but how diverse institutions can demonstrate that their screening and care arrangements deliver trustworthy, equitable, effective outcomes over time. That question provides the organizing agenda for the next generation of elite-sport mental health research.

References

  • Cosh, S. M., McNeil, D. G., Jeffreys, A., Clark, L., & Tully, P. J. (2024). Athlete mental health help-seeking: A systematic review and meta-analysis of rates, barriers and facilitators. Psychology of Sport and Exercise, 71, 102586. https://doi.org/10.1016/j.psychsport.2023.102586
  • Gouttebarge, V., Bilgoe, S. C., Gorczynski, P., Hitchcock, M. E., Putukian, M., Reardon, C. L., & Kerkhoffs, G. (2026). Supporting the IOC consensus statement on mental health in elite athletes: A systematic review and meta-analysis on the prevalence of mental health symptoms in elite sports. Sports, 14(7), 296. https://doi.org/10.3390/sports14070296
  • Gouttebarge, V., Bindra, A., Blauwet, C., Campriani, N., Currie, A., Engebretsen, L., Hainline, B., Kroshus, E., McDuff, D., Mountjoy, M., Purcell, R., Putukian, M., Reardon, C. L., Rice, S. M., & Budgett, R. (2021). International Olympic Committee (IOC) Sport Mental Health Assessment Tool 1 (SMHAT-1) and Sport Mental Health Recognition Tool 1 (SMHRT-1): Towards better support of athletes' mental health. British Journal of Sports Medicine, 55(1), 30–37. https://doi.org/10.1136/bjsports-2020-102411
  • Gouttebarge, V., Bindra, A., Blauwet, C., Currie, A., Hainline, B., Kroshus-Havril, E., McDuff, D., Purcell, R., Putukian, M., Reardon, C. L., Rice, S. M., Sloan, S., Thornton, J., & Mountjoy, M. (2026). International Olympic Committee Sport Mental Health Assessment Tool 2 (IOC SMHAT2): Development, content validity and feasibility. British Journal of Sports Medicine, 60(15), 1131–1142. https://doi.org/10.1136/bjsports-2025-111408
  • Gouttebarge, V., Castaldelli-Maia, J. M., Gorczynski, P., Hainline, B., Hitchcock, M. E., Kerkhoffs, G. M., Rice, S. M., & Reardon, C. L. (2019). Occurrence of mental health symptoms and disorders in current and former elite athletes: A systematic review and meta-analysis. British Journal of Sports Medicine, 53(11), 700–706. https://doi.org/10.1136/bjsports-2019-100671
  • Gulliver, A., Griffiths, K. M., & Christensen, H. (2012). Barriers and facilitators to mental health help-seeking for young elite athletes: A qualitative study. BMC Psychiatry, 12, 157. https://doi.org/10.1186/1471-244X-12-157
  • Gulliver, A., Griffiths, K. M., Christensen, H., Mackinnon, A., Calear, A. L., Parsons, A., Bennett, K., Batterham, P. J., & Stanimirovic, R. (2012). Internet-based interventions to promote mental health help-seeking in elite athletes: An exploratory randomized controlled trial. Journal of Medical Internet Research, 14(3), e69. https://doi.org/10.2196/jmir.1864
  • Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
  • Patricios, J. S., Schneider, K. J., Dvorak, J., Ahmed, O. H., Blauwet, C., Cantu, R. C., Davis, G. A., Echemendia, R. J., Makdissi, M., McNamee, M., Broglio, S., Emery, C. A., Feddermann-Demont, N., Fuller, G. W., Giza, C. C., Guskiewicz, K. M., Hainline, B., Iverson, G. L., Kutcher, J. S.,. Herring, S. A. (2023). Consensus statement on concussion in sport: The 6th International Conference on Concussion in Sport—Amsterdam, October 2022. British Journal of Sports Medicine, 57(11), 695–711. https://doi.org/10.1136/bjsports-2023-106898
  • Purcell, R., Gwyther, K., & Rice, S. M. (2019). Mental health in elite athletes: Increased awareness requires an early intervention framework to respond to athlete needs. Sports Medicine - Open, 5, 46. https://doi.org/10.1186/s40798-019-0220-1
  • Reardon, C. L., Gouttebarge, V., Kroshus-Havril, E., Miller Aron, C., Bahr, R., Blauwet, C., Castaldelli-Maia, J. M., Cheng, C., Currie, A., Derevensky, J. L., Edwards, C., Fussek, S., Gorczynski, P., Grandner, M., Han, D. H., Hitchcock, M. E., Lu, F., Massey, A., McDuff, D.,. Hainline, B. (2026). Mental health in elite athletes: International Olympic Committee consensus statement (2026). British Journal of Sports Medicine, 60(15), 1083–1130. https://doi.org/10.1136/bjsports-2025-111514
  • Reardon, C. L., Hainline, B., Miller Aron, C., Baron, D., Baum, A. L., Bindra, A., Budgett, R., Campriani, N., Castaldelli-Maia, J. M., Currie, A., Derevensky, J. L., Glick, I. D., Gorczynski, P., Gouttebarge, V., Grandner, M. A., Han, D. H., McDuff, D., Mountjoy, M., Polat, A.,. Engebretsen, L. (2019). Mental health in elite athletes: International Olympic Committee consensus statement (2019). British Journal of Sports Medicine, 53(11), 667–699. https://doi.org/10.1136/bjsports-2019-100715
  • Rice, S. M., Olive, L. S., Gouttebarge, V., Parker, A. G., Clifton, P., Harcourt, P., Lloyd, M., Kountouris, A., Smith, B., Busch, B., & Purcell, R. (2020). Mental health screening: Severity and cut-off point sensitivity of the Athlete Psychological Strain Questionnaire in male and female elite athletes. BMJ Open Sport & Exercise Medicine, 6(1), e000712. https://doi.org/10.1136/bmjsem-2019-000712
  • Rice, S. M., Purcell, R., De Silva, S., Mawren, D., McGorry, P. D., & Parker, A. G. (2016). The mental health of elite athletes: A narrative systematic review. Sports Medicine, 46(9), 1333–1353. https://doi.org/10.1007/s40279-016-0492-2
  • Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092
  • Tuakli-Wosornu, Y. A., Burrows, K., Fasting, K., Hartill, M., Hodge, K., Kaufman, K., Kavanagh, E., Kirby, S. L., MacLeod, J. G., Mountjoy, M., Parent, S., Tak, M., Vertommen, T., & Rhind, D. J. A. (2024). IOC consensus statement: Interpersonal violence and safeguarding in sport. British Journal of Sports Medicine, 58(22), 1322–1344. https://doi.org/10.1136/bjsports-2024-108766